4//SEC Filing
Sorrento Therapeutics, Inc. 4
Accession 0001209191-14-004852
CIK 0000850261operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:00 PM ET
Size
5.6 KB
Accession
0001209191-14-004852
Insider Transaction Report
Form 4
Salka Michael Scott
Director
Transactions
- Award
Stock Options
2014-01-23+10,000→ 38,000 totalExercise: $9.82Exp: 2024-01-23→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]3,333 of the original number of shares subject to this option shall vest and become exercisable on January 23, 2015 and 2016 and 3,334 shall vest and become exercisable on January 23, 2017, subject to the reporting person's continued service on the issuer's board of directors on each such date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850261
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:00 PM ET
- Size
- 5.6 KB